| Pharmaceutical Information |
| Drug Name |
Methamphetamine |
| Drug ID |
BADD_D01407 |
| Description |
Metamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug. It is a member of the amphetamine group of sympathomimetic amines. Methamphetamine can induce effects such as euphoria, increased alertness and energy, and enhanced self-esteem. It is a scheduled drug in most countries due to its high potential for addiction and abuse. |
| Indications and Usage |
For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity. |
| Marketing Status |
approved; illicit |
| ATC Code |
N06BA03 |
| DrugBank ID |
DB01577
|
| KEGG ID |
D08187
|
| MeSH ID |
D008694
|
| PubChem ID |
10836
|
| TTD Drug ID |
D0P6UB
|
| NDC Product Code |
Not Available |
| UNII |
44RAL3456C
|
| Synonyms |
Methamphetamine | Desoxyephedrine | Metamfetamine | Methylamphetamine | N-Methylamphetamine | N Methylamphetamine | Deoxyephedrine | Desoxyn | Madrine | Methamphetamine Hydrochloride | Hydrochloride, Methamphetamine |
|
| Chemical Information |
| Molecular Formula |
C10H15N |
| CAS Registry Number |
537-46-2 |
| SMILES |
CC(CC1=CC=CC=C1)NC |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
